GutSee Health is pioneering next-generation microbiome therapies by decoding complex gut–host interactions with advanced AI and multi-omics. Chronic gut disorders such as Inflammatory Bowel Disease (IBD) affect hundreds of millions worldwide, yet current treatments focus on symptom relief rather than addressing the root causes. Our proprietary AI Discovery Platform identifies molecular signatures that drive these disorders, enabling precision medicine therapies through two complementary strategies: • Restoring gut balance by adding consortia of therapeutic bacteria • Targeted removal of harmful microbes using bacteriophages - viruses that eliminate pathogenic bacteria without off-target effects. GutSee operates a technology-driven business model that combines cloud-based AI gut mining & complex mathematical modelling with bespoke therapeutic development, enabling scalable solutions and multiple revenue pathways through partnerships, licensing, and in-house therapeutic pipelines.